A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma

Cancer Research

Volumn 66, Issue 2, 2006, Pages 693-700

  Jiang, Ri Cheng ^a   Qin, Hai De ^a   Zeng, Mu Sheng ^a   Huang, Wei ^b   Feng, Bing Jian ^a   Zhang, Feng ^a   Chen, Han Kui ^a   Jia, Wei Hua ^a   Chen, Li Zhen ^a   Feng, Qi Sheng ^a   Zhang, Ru Hua ^a   Yu, Xing Juan ^a   Zheng, Mei Zhen ^a   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PALMITOYL COENZYME A HYDROLASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME 4P; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; EXON; FATTY ACID METABOLISM; FEMALE; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; LOC344967 GENE; MALE; NASOPHARYNX CANCER; NUCLEOTIDE SEQUENCE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHEAST ASIA; STATISTICAL SIGNIFICANCE; UPREGULATION;

CARCINOMA; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NASOPHARYNGEAL NEOPLASMS; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 31544450521     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2166     Document Type: Article

References (54)

1. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-9.
2. Zeng Y, Zhong JM, de-The G, Wu SH, Hou YT, Miao XQ. Enhancement of spontaneous VCA and EA induction in B95-8 cells and EA induction in Raji cells treated with human leukocyte interferon. Intervirology 1982;18:33-7.
3. Zeng YX, Jia WH. Familial nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:443-50.
4. Young LS, Rickinso AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-68.
5. Yang XR, Diehl S, Pfeiffer R, et al. Chinese and American Genetic Epidemiology of NPC Study Team. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005;14: 900-5.
6. Simons MJ, Wee GB, Chan SH, Shanmugaratnam K, Day NE, de-The G. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC. IARC Sci Publ 1975;249-58.
7. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002;94:1780-9.
8. Goldsmith DB, West TM, Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. Clin Otolaryngol Allied Sci 2002;27:61-7.
9. Pimtanothai N, Charoenwongse P, Mutirangura A, Hurley CK. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand. Tissue Antigens 2002;59:223-5.
10. Hirankarn N, Kimkong I, Mutirangura A. HLA-E polymorphism in patients with nasopharyngeal carcinoma. Tissue Antigens 2004;64:588-92.
11. Lu SJ, Day NE, Degos L, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990;346:470-1.
12. Lu CC, Chen JC, Jin YT, Yang HB, Chan SH, Tsai ST. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 2003; 103:745-51.
13. Lu CC, Chen JC, Tsai ST, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer 2005;115:742-6.
14. Hu SP, Day NE, Li DR, et al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005;92: 967-70.
15. Xiong W, Zeng ZY, Xia JH, et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004;64:972-4.
16. Chen Y, Chan SH. Polymorphism of T-cell receptor genes in nasopharyngeal carcinoma. Int J Cancer 1994; 56:830-3.
17. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 1999;8:547-51.
18. Hildesheim A, Chen CJ, Caporaso NE, et al. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995;4:607-10.
19. Hirunsatit R, Kongruttanachok N, Shotelersuk K, et al. Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer. BMC Genet 2003;4:3.
20. Jalbout M, Bouaouina N, Gargouri J, Corbex M, Ben Ahmed S, Chouchane L. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma. Cancer Lett 2003;193:75-81.
21. Cho EY, Hildesheim A, Chen CJ, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003;12:1100-4.
22. Xiong W, Zeng ZY, Li XL, et al. Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2002;34:512-5.
23. Huang H, Zhou YF, Jiang PZ, Shen XM, Yao KT. Screening of single nucleotide polymorphisms in nasopharyngeal carcinoma associated genes by denaturing high-performance liquid chromatography. Di Yi Jun Yi Da Xue Xue Bao 2002;22:602-4.
24. Duh FM, Fivash M, Moody M, et al. Characterization of a new SNP C767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer. Mol Cell Probes 2004;18:39-44.
25. Ren W, Zheng H, Li M, et al. A functional single nucleotide polymorphism site detected in nasopharyngeal carcinoma-associated transforming gene Tx. Cancer Genet Cytogenet 2005;157:49-52.
26. Jia WH, Collins A, Zeng YX. Complex segregation analysis of nasopharyngeal carcinoma in Guangdong, China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China). Eur J Hum Genet 2005;13:248-52.
27. Coffin CM, Rich SS, Dehner LP. Familial aggregation of nasopharyngeal carcinoma and other malignancies. A clinicopathologic description. Cancer 1991;68:1323-8.
28. Jia WH, Shao JY, Feng BJ, Zeng YX. Genetic component involved in nasopharyngeal carcinoma development. Cancer Reviews:Asia-Pacific 2003;1:31-49.
29. Jia WH, Feng BJ, Xu ZL, et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China. Cancer 2004;101:363-9.
30. Feng BJ, Huang W, Shugart YY, et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002;31:395-9.
31. Chen HK, Feng BJ, Liang H, Zhang R, Zeng YX. The susceptibility gene for familial nasopharyngeal carcinoma is mapped on chromosome 4p11-p14 by haplotype analysis. Chinese Science Bulletin 2003;48:2327-30.
32. Hillier LW, Graves TA, Fulton RS, et al. Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature 2005;434:724-31.
33. Bajic VB, Tan SL, Suzuki Y, Sugano S. Promoter prediction analysis on the whole human genome. Nat Biotechnol 2004;22:1467-73.
34. Christova R, Oelgeschlager T. Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo. Nat Cell Biol 2002;4:79-82.
35. Humbert O, Achour I, Lautier D, Laurent G, Salles B. hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure. Nucleic Acids Res 2003;31:5627-34.
36. Liang H, Chen H, Shen Y, et al. A rare polymorphism of the COX7B2 gene in a Cantonese family with nasopharyngeal carcinoma. Sci China C Life Sci 2004; 47:449-53.
37. Ranta S, Zhang Y, Ross B, et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 1999; 23:233-6.
38. Norio R. Finnish disease heritage I: characteristics, causes, background. Hum Genet 2003;112:441-56.
39. Laitinen T, Polvi A, Rydman P, et al. Characterization of a common susceptibility locus for asthma-related traits. Science 2004;304:300-4.
40. Xu J, Zheng SL, Komiya A, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002;32:321-5.
41. Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M. Mechanism of action of a novel latent membrane protein-1 dominant negative. J Biol Chem 2001;276: 1195-203.
42. Hatzivassiliou E, Mosialos G. Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci 2002;7:d319-29.
43. Dirmeier U, Hoffmann R, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 2005;24:1711-7.
44. Kondo S, Wakisaka N, Schell MJ, et al. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. Int J Cancer 2005;115:368-76.
45. Smith PR, Gao Y, Karran L, Jones MD, Snudden D, Griffin BE. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 1993;67:3217-25.
46. Broustas CG, Larkins LK, Uhler MD, Hajra AK. Molecular cloning and expression of cDNA encoding rat brain cytosolic acyl-coenzyme A thioester hydrolase. J Biol Chem 1996;271:10470-6.
47. Yamada J, Kuramochi Y, Takagi M, Watanabe T, Suga T. Human brain acyl-CoA hydrolase isoforms encoded by a single gene. Biochem Biophys Res Commun 2002; 299:49-56.
48. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-8.
49. Alo PL, Visca P, Trombetta G, et al. Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 1999;85:35-40.
50. Bull JH, Ellison G, Patel A, et al. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 2001;84:1512-9.
51. Furuya Y, Akimoto S, Yasuda K, Ito H. Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis. Anticancer Res 1997; 17:4589-93.
52. Gabrielson EW, Pinn ML, Testa JR, Kuhajda FP. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res 2001;7:153-7.
53. Kridel SJ, Axelrod F, Rozenkrantz N, Smith JW. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 2004;64:2070-5.
54. Sista ND, Barry C, Sampson K, Pagano J. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR α and RXR α. Nucleic Acids Res 1995;23:1729-36.